Literature DB >> 30345631

Continuous glucose monitoring defined glucose variability is associated with cardiovascular autonomic neuropathy in type 1 diabetes.

Ji Eun Jun1,2, Seung-Eun Lee1, You-Bin Lee3, Ji Yeon Ahn1, Gyuri Kim1, Kyu Yeon Hur1, Moon-Kyu Lee1, Sang-Man Jin1, Jae Hyeon Kim1,4.   

Abstract

BACKGROUND: The purpose of this study was to establish the association between continuous glucose monitoring (CGM)-defined glycaemic variability (GV) and cardiovascular autonomic neuropathy (CAN) in type 1 diabetes independent of mean glucose and to examine the relative contribution of each internationally standardized CGM parameter to this association.
MATERIALS AND METHODS: This study included 80 adults with type 1 diabetes who underwent 3-day CGM and autonomic function tests within 3 months. The degree of association between internationally standardized CGM parameters and CAN, defined as at least two abnormal parasympathetic tests or the presence of orthostatic hypotension, were analysed by logistic regression, receiver operating characteristics (ROC), and dominance analysis.
RESULTS: A total of 36 subjects (45.0%) were diagnosed with CAN. When adjusted with mean glucose and clinical risk factors of CAN, standard deviation, coefficient of variation, mean amplitude of glycaemic excursion, percent time in level 1 (glucose 54-69 mg/dL) and level 2 (glucose < 54 mg/dL) hypoglycaemia, area under the curve in level 2 hypoglycaemia, low blood glucose index, high blood glucose index, and percent time in glucose 70 to 180 mg/dL were independently associated with CAN. Multivariable ROC analysis and dominance analysis revealed the highest relative contribution of percent time in level 2 hypoglycaemia to the independent associations between CGM parameters and presence of CAN.
CONCLUSIONS: CGM-defined GV was associated with CAN independent of mean glucose in adults with type 1 diabetes. Among internationally standardized CGM parameters, those describing the degree of level 2 hypoglycaemia were the most significant contributors to this association.
© 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  cardiovascular autonomic neuropathy; continuous glucose monitoring; hypoglycaemia; type 1 diabetes mellitus

Mesh:

Substances:

Year:  2018        PMID: 30345631     DOI: 10.1002/dmrr.3092

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  12 in total

Review 1.  The early detection of atherosclerosis in type 1 diabetes: why, how and what to do about it.

Authors:  Alicia Jenkins; Andrzej Januszewski; David O'Neal
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-02-13

2.  Randomized Study Comparing Vildagliptin vs Glibenclamide on Glucose Variability and Endothelial Function in Patients with Type 2 Diabetes Mellitus and Hypertension.

Authors:  Luciana Neves Cosenso-Martin; Lais Yumi Takaoka; Jose Fernando Vilela-Martin
Journal:  Diabetes Metab Syndr Obes       Date:  2020-09-15       Impact factor: 3.168

3.  Effect of Dapagliflozin on Glycemic Variability in Patients with Type 2 Diabetes under Insulin Glargine Combined with Other Oral Hypoglycemic Drugs.

Authors:  Menghui Luo; Xiaocen Kong; Huiying Wang; Xiaofang Zhai; Tingting Cai; Bo Ding; Yun Hu; Ting Jing; Xiaofei Su; Huiqin Li; Jianhua Ma
Journal:  J Diabetes Res       Date:  2020-11-24       Impact factor: 4.011

Review 4.  Glycaemic variability: The under-recognized therapeutic target in type 1 diabetes care.

Authors:  Emma G Wilmot; Pratik Choudhary; Lalantha Leelarathna; Mike Baxter
Journal:  Diabetes Obes Metab       Date:  2019-08-26       Impact factor: 6.577

5.  Association of Urinary N-Acetyl-β-D-Glucosaminidase with Cardiovascular Autonomic Neuropathy in Type 1 Diabetes Mellitus without Nephropathy.

Authors:  Min Sun Choi; Ji Eun Jun; Sung Woon Park; Jee Hee Yoo; Jiyeon Ahn; Gyuri Kim; Sang-Man Jin; Kyu Yeon Hur; Moon-Kyu Lee; Jae Hyeon Kim
Journal:  Diabetes Metab J       Date:  2021-02-02       Impact factor: 5.376

Review 6.  The Role of Glucagon in Glycemic Variability in Type 1 Diabetes: A Narrative Review.

Authors:  Keyu Guo; Qi Tian; Lin Yang; Zhiguang Zhou
Journal:  Diabetes Metab Syndr Obes       Date:  2021-12-21       Impact factor: 3.168

7.  Evaluating Glycemic Control During Basalin or Lantus Administration in Adults With Controlled Type 2 Diabetes Mellitus Using Continuous Glucose Monitoring.

Authors:  Huiying Wang; Yunting Zhou; Xiaofang Zhai; Bo Ding; Ting Jing; Xiaofei Su; Huiqin Li; Jianhua Ma
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-30       Impact factor: 5.555

8.  Association of glycemic variability and hypoglycemia with distal symmetrical polyneuropathy in adults with type 1 diabetes.

Authors:  Ziyang Shen; Hemin Jiang; Rong Huang; Yunting Zhou; Qian Li; Jianhua Ma
Journal:  Sci Rep       Date:  2021-11-24       Impact factor: 4.379

9.  Time in Range, as a Novel Metric of Glycemic Control, Is Reversely Associated with Presence of Diabetic Cardiovascular Autonomic Neuropathy Independent of HbA1c in Chinese Type 2 Diabetes.

Authors:  Qingyu Guo; Pu Zang; Shaoying Xu; Wenjing Song; Zhen Zhang; Chunyan Liu; Zhanhong Guo; Jing Chen; Bin Lu; Ping Gu; Jiaqing Shao
Journal:  J Diabetes Res       Date:  2020-02-06       Impact factor: 4.011

10.  Flash glucose monitoring reduces glycemic variability and hypoglycemia: real-world data from Spain.

Authors:  Fernando Gomez-Peralta; Timothy Dunn; Katherine Landuyt; Yongjin Xu; Juan Francisco Merino-Torres
Journal:  BMJ Open Diabetes Res Care       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.